1,695
Views
3
CrossRef citations to date
0
Altmetric
Professional

Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2013

&
Pages 473-478 | Received 07 Jun 2016, Accepted 15 Nov 2016, Published online: 07 Jan 2017
Supplemental material

Copy_of_AuthorResponsetoReviewer_vn3_31OCT.xlsx

Download MS Excel (10.3 KB)

Zaltrap2013.pdf

Download PDF (36 KB)

Xofigo2013.pdf

Download PDF (35 KB)

Vitekta2013.pdf

Download PDF (32.9 KB)

Vipidia2013.pdf

Download PDF (34 KB)

Tresiba2013.pdf

Download PDF (37.1 KB)

Tafinlar2013.pdf

Download PDF (32.8 KB)

Stribild2013.pdf

Download PDF (33.2 KB)

Stivarga2013.pdf

Download PDF (33.7 KB)

Selincro2013.pdf

Download PDF (34 KB)

Ryzodeg2013.pdf

Download PDF (36.8 KB)

Relvar_ellipta2013.pdf

Download PDF (33.3 KB)

Provenge2013.pdf

Download PDF (34.5 KB)

Perjeta2013.pdf

Download PDF (32.8 KB)

Opsumit2013.pdf

Download PDF (32.2 KB)

NovoEight2013.pdf

Download PDF (32.3 KB)

Lyxumia2013.pdf

Download PDF (34.9 KB)

Lonquex2013.pdf

Download PDF (33 KB)

Lojuxta2013.pdf

Download PDF (35.4 KB)

Krystexxa2013.pdf

Download PDF (33.6 KB)

Kadcyla2013.pdf

Download PDF (34.7 KB)

Invokana2013.pdf

Download PDF (33.6 KB)

Imnovid2013.pdf

Download PDF (32.7 KB)

Iclusig2013.pdf

Download PDF (32.3 KB)

Giotrif2013.pdf

Download PDF (34.6 KB)

Erivedge2013.pdf

Download PDF (32.4 KB)

Brintellix2013.pdf

Download PDF (33.8 KB)

Bosulif2013.pdf

Download PDF (33.1 KB)

BindRen2013.pdf

Download PDF (34.5 KB)

Aubagio2013.pdf

Download PDF (32.9 KB)

2013SupplementarySheet_34NewMedicines.pdf

Download PDF (66.2 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.